 |
|
Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older
Ah-Leum Ahn, Jae-Kyung Choi, Mi-Na Kim, Seun-Ah Kim, Eun-Jung Oh, Hyuk-Jung Kweon, Dong-Yung Cho
Korean J Fam Med. 2013;34(3):199-205. Published online 2013 May 24 DOI: https://doi.org/10.4082/kjfm.2013.34.3.199
|
|
Citations to this article as recorded by
 Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis
Marc Gurun, Paul Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F. Dillon, Christopher J. Byrne, Anna Di Sessa
PLOS ONE.2024; 19(4): e0299507. CrossRef Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk
Jacob Nysather, Eda Kaya, Paul Manka, Prakash Gudsoorkar, Wing-Kin Syn
Advances in Kidney Disease and Health.2023; 30(4): 315. CrossRef Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease
Ziwen Tao, Yueyue Li, Baoquan Cheng, Tao Zhou, Yanjing Gao
Journal of Clinical and Translational Hepatology.2022; 10(1): 164. CrossRef Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Diabetologia.2022; 65(3): 518. CrossRef Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease
Mehmet Kanbay, Mustafa C. Bulbul, Sidar Copur, Baris Afsar, Alan A. Sag, Dimitrie Siriopol, Masanari Kuwabara, Silvia Badarau, Adrian Covic, Alberto Ortiz
Journal of Nephrology.2021; 34(3): 649. CrossRef Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study
Ana J. F. C. Aguiar, Jaluza L. C. de Queiroz, Pedro P. A. Santos, Christina S. Camillo, Alexandre C. Serquiz, Izael S. Costa, Gerciane S. Oliveira, Ana F. T. Gomes, Lídia L. R. Matias, Rafael O. A. Costa, Thaís S. Passos, Ana H. A. Morais
International Journal of Molecular Sciences.2021; 22(18): 9968. CrossRef Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos
Annals of Hepatology.2020; 19(2): 134. CrossRef Association of nonalcoholic fatty liver and chronic kidney disease: An analysis of 37,825 cases from health checkup center in Taiwan
Hao-Wen Liu, Jia-Sin Liu, Ko-Lin Kuo
Tzu Chi Medical Journal.2020; 32(1): 65. CrossRef NAFLD as a driver of chronic kidney disease
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology.2020; 72(4): 785. CrossRef Correlation Between Non-Alcoholic Fatty Liver and Chronic Kidney Disease
Hasyim Kasim, St. Rabiul Zatalia, Haerani Rasyid, Syakib Bakri, Muhammad L. Parewangi, Fardah Akil, Arifin Seweng
The Open Urology & Nephrology Journal.2020; 13(1): 1. CrossRef Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
Andrew A. Li, Aijaz Ahmed, Donghee Kim
Gut and Liver.2020; 14(2): 168. CrossRef Risk of Kidney Dysfunction IN Nafld
Alessandro Mantovani, Chiara Zusi, Andrea Dalbeni, Giorgio Grani, Elena Buzzetti
Current Pharmaceutical Design.2020; 26(10): 1045. CrossRef Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease
Rajkumar Chinnadurai, James Ritchie, Darren Green, Philip A Kalra
Nephrology Dialysis Transplantation.2019; 34(3): 449. CrossRef Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis
Robert M. Wilechansky, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Emelia J. Benjamin, Michelle T. Long
Liver International.2019; 39(8): 1535. CrossRef Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity‐matched cohort study
Haesuk Park, Ghadeer K. Dawwas, Xinyue Liu, Mindie H. Nguyen
Journal of Internal Medicine.2019; 286(6): 711. CrossRef Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
Leon A Adams, Quentin M Anstee, Herbert Tilg, Giovanni Targher
Gut.2017; 66(6): 1138. CrossRef Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
Giovanni Targher, Christopher D. Byrne
Nature Reviews Nephrology.2017; 13(5): 297. CrossRef Nonalcoholic fatty liver disease - A multisystem disease?
Ivana Mikolasevic, Sandra Milic, Tamara Turk Wensveen, Ivana Grgic, Ivan Jakopcic, Davor Stimac, Felix Wensveen, Lidija Orlic
World Journal of Gastroenterology.2016; 22(43): 9488. CrossRef NAFLD: A multisystem disease
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology.2015; 62(1): S47. CrossRef Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes
Yongqiang Li, Shuangshuang Zhu, Bin Li, Xiaofei Shao, Xinyu Liu, Aiqun Liu, Bifang Wu, Ying Zhang, Honglei Wang, Xiaohong Wang, Kangping Deng, Qin Liu, Min Huang, Hongmei Liu, Harry Holthöfer, Hequn Zou
International Urology and Nephrology.2014; 46(9): 1785. CrossRef Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
Ki-Chul Sung, Sarah H. Wild, Christopher D. Byrne
Journal of Hepatology.2014; 60(5): 1040. CrossRef Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Giovanni Musso, Roberto Gambino, James H. Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar
PLoS Medicine.2014; 11(7): e1001680. CrossRef CKD and Nonalcoholic Fatty Liver Disease
Giovanni Targher, Michel B. Chonchol, Christopher D. Byrne
American Journal of Kidney Diseases.2014; 64(4): 638. CrossRef
|